SCHEMBL4005161

SCHEMBL4005161

c1csc(-c2cncc(N3CC4CNC(C4)C3)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.55
CHRNA4 P43681 3/20 0.55
CHRNB4 P30926 7/20 0.49
CHRNA3 P32297 7/20 0.49
CHRNA7 P36544 2/20 0.40
CYP2E1 P05181 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2A6 P11509 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2B6 P20813 1/20 0.38
CHRNB1 P11230 1/20 0.37
CHRNB3 Q05901 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4005463 0.87 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL13767937 0.83 CHRNB2 (0.64) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL4012065 0.82 CHRNB2 (0.50) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL4003627 0.82 CHRNB4 (0.73) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL4007434 0.82 CHRNB4 (0.73) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL13767889 0.80 CHRNB2 (0.74) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL4012353 0.79 CHRNB4 (0.57) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL4012942 0.79 CHRNB4 (0.73) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL4008509 0.79 CHRNB4 (0.57) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL13767973 0.78 CHRNB4 (0.55) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009081246-A2 BICYCLIC DIAMINES AS NICOTINIC RECEPTOR AGONISTS PFIZER INC. (US) 2009-07-02 WO claimed
WO-2009081246-A2 BICYCLIC DIAMINES AS NICOTINIC RECEPTOR AGONISTS PFIZER INC. (US) 2009-07-02 WO disclosed